Secondary tabs
Contact details
Claus Møldrup clml@dkma.dk
Main
Claus Møldrup elvb@dkma.dk
Alternate
Publications
Data source publications
- The Danish National Patient Registry: a review of content, data quality, and research potential
- The Danish Cancer Registry
- The Danish vaccination register
- The Danish National Prescription Registry
- Existing Data Sources in Clinical Epidemiology: Laboratory Information System Databases in Denmark
- The Danish Civil Registration System
Studies
List of studies that have been conducted using the data source
- SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
- SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources. (SAFETY VAC)
- SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources.
- DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics
- A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UK (C3671026)
- DARWIN EU® -Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products
- Assessing the Risk of Falls and Fractures in Older Adults with Diabetic Polyneuropathy Initiated on Gabapentinoids, SNRIs, or TCAs: An Observational Study (SAFER-PDPN)
- DARWIN EU® - Suicidality incidence rates in adult male patients and in patients treated with finasteride and dutasteride
- DARWIN EU® - Characterisation of exposure to acitretin and purpura and related conditions
- DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries
- DARWIN EU® - Prescription trends of ketamine and esketamine
- DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
- DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives
- DARWIN EU® Drug Utilisation Study of prescription opioids
- Brand-specific influenza vaccine effectiveness in the Nordic countries
- Generalizability and clinical outcomes of first-line pembrolizumab for stage IV NSCLC: insights from a nationwide real-world cohort compared to pivotal trials
- DARWIN EU® - Clozapine and the incidence of agranulocytosis over time
- DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - Antipsychotic prescribing in children in Europe: a descriptive analysis of trends and patient characteristics
- Real-World Incidence of Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Denmark
- Potential Adverse Drug Reactions Associated with Chlorzoxazone - Using Symmetry Analysis
- DARWIN EU® - Characterisation of acute renal outcomes and diabetic complications among patients with concomitant use of metformin and iodinated contrast agents
- DARWIN EU® - Drug utilisation study on antibiotics in the ‘Access’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
- DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Reserve’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
- DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
- DARWIN EU® - Uptake of meningococcal vaccines by the target population in Europe
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications